Skip to main content

Advertisement

Table 3 Correlation of MUC20 expression with clinicopathologic features in CRC patients

From: Role of MUC20 overexpression as a predictor of recurrence and poor outcome in colorectal cancer

Clinicopathologic features n MUC20 expression n (%) χ2 P
Positive Negative
Gender     0.787 0.375
 Male 88 56(63.6%) 32(26.4%)   
 Female 62 35(56.5%) 27(43.5%)   
Age(years)     4.261 0.039
 <60 94 63(67.0%) 31(33.0%)   
 > = 60 56 28(50.0%) 28(50.0%)   
Tumor size (diameter)    1.189 0.276
 <5 87 56(64.4%) 31(35.6%)   
 > = 5 63 35(55.6%) 28(44.4%)   
Location     0.224 0.636
 Colon 100 62(62.0%) 38(38.0%)   
 Rectum 50 29(58.0%) 21(42.0%)   
Gross appearance     0.685 0.710
 Exophytic 60 34(56.7%) 26(43.3%)   
 Ulcerative 87 55(63.2%) 32(36.8%)   
 Diffusely infiltrative 3 2(66.7%) 1(33.3%)   
Differentiation     0.086 0.958
 High 7 4(57.1%) 3(42.9%)   
 Moderate 111 67(60.4%) 44(39.6%)   
 Low 32 20(62.5%) 12(37.5%)   
TNM stage     0.264 0.607
 II 80 47(58.8%) 33(41.2%)   
 III 70 44(62.9%) 26(37.1%)   
Recurrence     5.849 0.016
 Yes 47 36(76.6%) 11(33.4%)   
 No 90 50(55.6%) 40(44.4%)   
Status     5.960 0.015
 Survival 93 52(55.9%) 41(44.1%)   
 Death 41 32(78.0%) 9(22.0%)